Pharma Manufacturing Engages in Industry 4.0

Article

New manufacturing and control technologies are being explored.

Industry 4.0-the paradigm of connecting physical systems by direct machine-to-machine communications via the Industrial Internet of Things-promises to improve efficiency, and companies across the pharmaceutical industry are embracing “digital transformation.” Merck, for example, seeks to connect “smart factories” for responsive and adaptive manufacturing (1). Pfizer is moving towards “connected manufacturing plants” that make data visible and available on demand (1). Sanofi is employing “digital twins” to simulate their biopharma manufacturing processes, as well as using collaborative robots, augmented reality, and paperless operations (1). 

Learn more at CPhI WorldWide 2018, which will feature a Keynote Session Discussion panel on creating an Industry 4.0 Strategy for manufacturing. 

References

1.    J. Markarian, PharmTech, 42 (4) 20-25 (2018)

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Related Content